2012-09-13
Risk dimension: is M&A and strategic partnering amongst pharmaceutical firms risk reducing?
Publication
Publication
an explorative research involving competition
Additional Metadata | |
---|---|
, , | |
Rosch, D.M., Fan, Y. | |
hdl.handle.net/2105/25634 | |
Finance & Investments | |
Organisation | Rotterdam School of Management |
Roozendaal, H.C.F. (2012, September 13). Risk dimension: is M&A and strategic partnering amongst pharmaceutical firms risk reducing?. Finance & Investments. Retrieved from http://hdl.handle.net/2105/25634
|